InvestorsHub Logo

Hugon

11/23/21 11:08 AM

#385111 RE: kfcyahoo #385095

The next press release will be fascinating. Let’s see it

CallMeCrazy

11/23/21 11:16 AM

#385113 RE: kfcyahoo #385095

NOT true Kfcyahoo!

You said:

Kevetrin died years ago. Ask the two patients(total patients enrolled) in the last , and only, phase 2 trial of that “ wonder drug.


February 8, 2018
Innovation Pharmaceuticals Concludes Successful Phase 2a Trial of Kevetrin for Ovarian Cancer; Intra-Tumor Modulation of p53 Observed

Throughout pre-clinical testing and two successful clinical trials, Kevetrin has demonstrated promising signs of efficacy as an anti-cancer agent and a favorable pharmacokinetic profile that includes a very short half-life and good bioavailability. It is believed that these characteristics make Kevetrin an ideal candidate for oral delivery (capsule or tablet), which will facilitate convenient and frequent dosing, perhaps even multiple times daily, to maximize the therapeutic benefit of the compound.


http://www.ipharminc.com/press-release/2018/2/8/innovation-pharmaceuticals-concludes-successful-phase-2a-trial-of-kevetrin-for-ovarian-cancer-intra-tumor-modulation-of-p53-observed